Is pertuzumab a chemo drug?
Pertuzumab is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. This medication is classified as an “antineoplastic agent and a monoclonal antibody”.
How often is Phesgo given?
Administer PHESGO every 3 weeks for a total of 1 year (up to 18 cycles) or until disease recurrence or unmanageable toxicity, whichever occurs first, as part of a complete regimen for early breast cancer, including standard anthracycline- and/or taxane-based chemotherapy.
Does pertuzumab cause hair loss?
Pertuzumab and trastuzumab do not usually cause people to lose their hair. Any hair loss caused by chemotherapy should be temporary and in most cases your hair will begin to grow back once your chemotherapy has ended.
Does PHESGO cause weight gain?
Symptoms to watch for include swelling of the ankles or legs, shortness of breath, cough, or weight gain of more than 5 pounds in less than 24 hours.
Does PHESGO cause hair loss?
The most common side effects of PHESGO when given with chemotherapy as part of an early breast cancer regimen are: Hair Loss. Nausea.
Do pertuzumab and trastuzumab cause hair loss?
Does pertuzumab cause skin and nail changes?
Nail Changes and Rash Your fingernails/toenails may become dark, brittle, or fall off. Keep your fingernails and toenails clean and dry. You may use nail polish, but do not wear fake nails (gels, acrylics, overlay).
How long can you take pertuzumab?
Before surgery, pertuzumab is given for three to six cycles alongside trastuzumab and chemotherapy. After surgery, it’s given alongside trastuzumab and chemotherapy for around one year. Some people have pertuzumab before and after surgery. Up to 18 cycles can be given in total.
Is PHESGO a chemo drug?
Breast cancer patients undergoing chemotherapy will be offered a new combined treatment called PHESGO, which is injected and takes as little as five minutes to prepare and administer, compared with two infusions that can take up to two and a half hours.
Is PHESGO chemotherapy?
Is pertuzumab an immunotherapy?
Passive immunotherapy has provided several successful treatments for breast cancer. The current mainstay of passive immunotherapy includes trastuzumab, pertuzumab, and trastuzumab emtansine (T-DM1).
Does PHESGO make your hair fall out?
The most common side effects of PHESGO when given with chemotherapy as part of an early breast cancer regimen are hair loss, nausea, diarrhea, low levels of red blood cells, and weakness.
Is pertuzumab a chemo or immunotherapy?
Chemotherapy drugs, such as docetaxel, carboplatin, trastuzumab, pertuzumab, and pegfilgrastim, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.